Sudarshan Pharma Industries is currently trading at Rs. 51.50, up by 0.52 points or 1.02% from its previous closing of Rs. 50.98 on the BSE.
The scrip opened at Rs. 53.49 and has touched a high and low of Rs. 53.50 and Rs. 51.00 respectively. So far 328000 shares were traded on the counter.
The BSE group 'MT' stock of face value Rs. 1 has touched a 52 week high of Rs. 53.50 on 07-Jan-2025 and a 52 week low of Rs. 5.82 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 53.50 and Rs. 44.10 respectively. The current market cap of the company is Rs. 1227.36 crore.
The promoters holding in the company stood at 57.39%, while Institutions and Non-Institutions held 13.07% and 29.54% respectively.
Sudarshan Pharma Industries has entered into a Rent Agreement with Daundi Biological to acquire premises for a period of 5 years commencing from December 29, 2024 to set up a new Research & Development formulation centre in the city of Dehradun, Uttarakhand, India. It is expected to commence the operations of the formulation R&D Centre in the month of March 2025.
Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: